Entrepreneurs developing cleantech technologies are invited to apply to pitch to investors at Cleantech Venture Day in London next February.
The two-day event will bring together innovative, investment-ready cleantech companies with fund managers, business angels and corporate investors.
Organisers Oxfordshire Greentech, Cambridge Cleantech and Avanto Ventures say firms with technologies making a positive difference in fields such as energy, waste, buildings and carbon reduction, for the broader benefits of society are especially welcome to apply.
CleanTech Venture Day takes place February 11 and 12 at KPMG’s members’ club, Number Twenty, Grosvenor Street, W1K 4QJ.
Applications are open until November 15.
Oxford biotech company e-therapeutics is offering its powerful network-biology-and AI-based drug discovery platform to help tackle the Covid-19 pandemic.
The OxVent ventilator for Covid-19 patients, developed in just two weeks in March by engineers and medics in Oxford and London, is being tested for safety and usability at the Smith+Nephew medical manufacturing facility in Hull.
Researchers in Oxford and Zurich have used artificial intelligence (AI) and computer visualisation technology to detect changes in colon cancer cells that could be connected to the ‘expression’ of some smell-sensing genes.
Matthew Cobb’s book charts the history of efforts to understand the brain and brings us up to date with the latest developments in neuroscience.